Page last updated: 2024-10-30

metformin and Ambulation Disorders, Neurologic

metformin has been researched along with Ambulation Disorders, Neurologic in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Metformin, the well-known anti-diabetic drug, has been shown recently to improve the grip test performance of the DMSXL mouse model of myotonic dystrophy type 1."9.27Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial. ( Arrouasse, R; Audureau, E; Baghdoyan, S; Bassez, G; Bhugaloo, H; Gourlay-Chu, ML; Hogrel, JY; Le Corvoisier, P; Peschanski, M, 2018)
"Metformin, the well-known anti-diabetic drug, has been shown recently to improve the grip test performance of the DMSXL mouse model of myotonic dystrophy type 1."5.27Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial. ( Arrouasse, R; Audureau, E; Baghdoyan, S; Bassez, G; Bhugaloo, H; Gourlay-Chu, ML; Hogrel, JY; Le Corvoisier, P; Peschanski, M, 2018)
"No significant difference in the other treatment groups."1.48Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia. ( Hamilton, W; Hattersley, AT; Hope, SV; Shields, BM; Taylor, PJ, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hope, SV1
Taylor, PJ1
Shields, BM1
Hattersley, AT1
Hamilton, W1
Bassez, G1
Audureau, E1
Hogrel, JY1
Arrouasse, R1
Baghdoyan, S1
Bhugaloo, H1
Gourlay-Chu, ML1
Le Corvoisier, P1
Peschanski, M1

Trials

1 trial available for metformin and Ambulation Disorders, Neurologic

ArticleYear
Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial.
    Brain : a journal of neurology, 2018, 10-01, Volume: 141, Issue:10

    Topics: Adult; Double-Blind Method; Female; Gait; Gait Disorders, Neurologic; Humans; Hypoglycemic Agents; M

2018

Other Studies

1 other study available for metformin and Ambulation Disorders, Neurologic

ArticleYear
Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia.
    Primary care diabetes, 2018, Volume: 12, Issue:2

    Topics: Accidental Falls; Age Factors; Aged; Biomarkers; Blood Glucose; Cross-Sectional Studies; Diabetes Me

2018
chemdatabank.com